BPC-157 (Body Protection Compound-157, Bepecin, PL 14736) is a synthetic 15-amino acid pentadecapeptide derived from a naturally occurring gastric juice protein [citation:1][citation:8]. First isolated and characterized in 1993, this stable peptide exhibits remarkable resistance to enzymatic degradation in gastric acid (ex vivo stability ≥24 hours) and demonstrates pleiotropic cytoprotective, angiogenic, and tissue-regenerative properties across multiple organ systems [citation:1][citation:8]. Unlike conventional growth factors, BPC-157 activates distinct signaling pathways involving VEGFR2-Akt-eNOS and growth hormone receptor expression, positioning it as a unique research tool for investigating wound healing, musculoskeletal repair, gastrointestinal mucosal integrity, and vascular protection in controlled preclinical models [citation:1][citation:2][citation:3].